KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $60M
- YoY, 2025
- +8.9%
- 5-year CAGR
- +63.1%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $60M | +8.9% |
| 2024 | $55M | +27.6% |
| 2023 | $43M | +21.5% |
| 2022 | $35M | +42.1% |
| 2021 | $25M | +381.2% |
| 2020 | $5.2M | +333.9% |
| 2019 | $1.2M | — |